Parviz Vahedi1, Asghar Rajabzadeh2,3, Ali Soleimani4. 1. Department of Anatomical Sciences, Maragheh University of Medical Sciences, Maragheh, Iran. 2. Razi Herbal Medicines Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. 3. Department of Anatomical Sciences, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran. 4. Department of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran.
Abstract
Objectives: Lead exposure has destructive effects on some organs. It may produce a variety of toxic effects on endothelial cells of the vascular system. Any changes or damages to endothelial cells may lead to cardiovascular diseases, particularly the formation of atherosclerotic plaques. The aim of this study was to determine the ameliorative effects of ascorbic acid on the endothelium of coronary and aorta arteries in lead-exposed rabbits. Methods: In this study, 30 white male rabbits of New Zealand race (weighing about 1.6-2 kg and 5 months old) were used and divided randomly into three groups: Group 1 (N = 10) that served as the control and received water and normal diet, Group 2 (N = 10) was exposed to lead acetate 547 ppm (5 mg/L) daily for 40 days, and Group 3 (N = 10) received vitamin C (500 mg/kg) and underwent the same duration of lead exposure (5 mg/L) daily for 40 days. The levels of cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein were measured using spectrophotometry, and the level of blood lead was calculated using a lead analyzer (Magellan Diagnostics, USA). The animals were anesthetized by pentobarbital (50 mg/kg). Subsequently, they were sacrificed, and their thoracic aortas and coronary arteries were removed. Then fixation, tissue processing, histological sectioning, and H & E staining were carried out. Finally, the sections were studied using light microscopy. The results were analyzed using the Mann-Whitney test. Results: The results indicated that ascorbic acid could reduce the destructive effects of lead on vascular endothelial cells and prevent the formation of atherosclerotic plaques in coronary and aorta arteries. Conclusion: The results of this study confirm the beneficial effects of ascorbic acid against the destructive effects of lead on vascular endothelial cells. Hence, it could be proposed as a potential prophylactic treatment for the amelioration of lead toxicity, prevention of atherosclerosis, and improvement of endothelial cells dysfunction.
Objectives: Lead exposure has destructive effects on some organs. It may produce a variety of toxic effects on endothelial cells of the vascular system. Any changes or damages to endothelial cells may lead to cardiovascular diseases, particularly the formation of atherosclerotic plaques. The aim of this study was to determine the ameliorative effects of ascorbic acid on the endothelium of coronary and aorta arteries in lead-exposed rabbits. Methods: In this study, 30 white male rabbits of New Zealand race (weighing about 1.6-2 kg and 5 months old) were used and divided randomly into three groups: Group 1 (N = 10) that served as the control and received water and normal diet, Group 2 (N = 10) was exposed to lead acetate 547 ppm (5 mg/L) daily for 40 days, and Group 3 (N = 10) received vitamin C (500 mg/kg) and underwent the same duration of lead exposure (5 mg/L) daily for 40 days. The levels of cholesterol, triglyceride, low-density lipoprotein, and high-density lipoprotein were measured using spectrophotometry, and the level of blood lead was calculated using a lead analyzer (Magellan Diagnostics, USA). The animals were anesthetized by pentobarbital (50 mg/kg). Subsequently, they were sacrificed, and their thoracic aortas and coronary arteries were removed. Then fixation, tissue processing, histological sectioning, and H & E staining were carried out. Finally, the sections were studied using light microscopy. The results were analyzed using the Mann-Whitney test. Results: The results indicated that ascorbic acid could reduce the destructive effects of lead on vascular endothelial cells and prevent the formation of atherosclerotic plaques in coronary and aorta arteries. Conclusion: The results of this study confirm the beneficial effects of ascorbic acid against the destructive effects of lead on vascular endothelial cells. Hence, it could be proposed as a potential prophylactic treatment for the amelioration of lead toxicity, prevention of atherosclerosis, and improvement of endothelial cells dysfunction.
According to the World Health Organization (WHO), cardiovascular disease (CVD)
is one of the major causes of death in the world, and it is predicted that
by 2030, about 32 million people will die due to CVD. Lead is available
everywhere and its wide distribution pollutes the environment.Lead is one of the heavy metals whose toxic effects have been known as a major
environmental health hazard worldwide affecting both humans and animals at
all ages, particularly young human offsprings.[2,3]Available elements surrounding human beings have different effects on his
health. Some of these elements are useful for human health and some are
harmful. Lead has no beneficial role in the human body and the presence of
any amount of it is considered a risk factor.Many studies have provided noticeable amounts of data about
free-radical-mediated injury in the wall of the vasculature. Several
mechanisms cause oxidative stress. One of the important mechanisms is
related to lead that is associated with the lack of balance between
antioxidants level and the generation of free radicals. Oxidative
stress-induced lipid peroxidation involved atherosclerosis. Recent studies
have shown that increased oxidative stress is an important mediator of
endothelial damage associated with increased oxidant protein production,
such as hydrogen peroxide superoxidation, decreased nitric oxide synthesis,
and decreased biological antioxidant capacity. Oxidative stress is
associated with endothelial dysfunction, inflammation, hypertrophy,
fibrosis, and vascular deformity.[5,6]CVDs have been referred to in some studies as the major cause of mortality and
diseases around the world. Different environmental risk factors cause the
CVDs. However, air pollution is currently known as the most common
environmental risk factor for CVDs.Previous studies have demonstrated that lead exposure could damage some body
systems. It may effect on endothelial cells lining luminal surface of the
vascular system. Damages of endothelial cells may lead to CVDs, particularly
the formation of atherosclerotic plaques.[8,9]There are many factors with antioxidant properties and scavenger of reactive
oxygen species (ROS). Ascorbic acid is one of the antioxidants which are
easily accessible for humans.Vitamin C has an important role in scavenging free radicals and
atherosclerosis. It inhibits the development and progression of
atherosclerosis, a vascular disease caused by antioxidants.Certain studies have shown that oral administration of ascorbic acid may result
in lead chelation and reduce the risk of heavy metal poisoning. According to
the results of some studies conducted on mice, ascorbic acid reduces
intestinal absorption of lead and increases renal filtration. This vitamin
is a Lactone with an Enediol group that can be combined with lead to form a
very low ionic but water-soluble compound.[12,13]Hence, it was presumed that the use of ascorbic acid could be an alternative
method for lead poisoning therapy. Specifically, ascorbic acid is known as
an antioxidant that reduces the effects of lead in the body. It has been
widely reported that it can protect the cells from the toxic effects of lead.
A study has reported that vitamin C chelates lead ions. However, some
studies have shown a negative relationship between the level of vitamin C in
the blood and lead concentration. Moreover, previous studies have indicated
that vitamin C cannot scavenge the lead ions.It has been shown that lead decreases nitric oxide production in endothelial
cells, which is one of the major factors in the regulation of the vascular
tone. Moreover, nitric oxide can regulate attachment of leukocytes to
endothelium, duplication of smooth muscle cells in vessels’ wall and
platelet aggregation.It has been shown in a study that vitamin C cannot scavenge the lead ions.
Furthermore, previous studies have demonstrated that vitamin C has an
essential role in a number of applications related to the pathogenesis of
CVD. Patra et al. reported that vitamin C may not significantly reduce blood
lead level in accordance with similar previous findings. They suggested that
treatment by vitamin C may not be effective on the reduction of the lead
level in vessels and other tissues.Since, there are several challenges with regard to treatment by vitamin C, and
the studies conducted on the therapeutic efficiency of vitamin C are
insufficient to determine its effect on the treatment process in the animal
models.To our knowledge, no study has been accomplished on the vitamin C effects on
coronary and aorta artery endothelial cells after lead exposure in male
rabbits. So this study was conducted to investigate the probable therapeutic
role of ascorbic acid against injury induced by lead in vascular endothelial
cells.
Methods
This experimental study was carried out in Maragheh University of Medical
Sciences and was approved by the Research Ethics Committee of the Faculty of
Medicine, Maragheh University of Medical Sciences
(IR.MARAGHEHPHC.REC.1399.019). In this study, 30 white male rabbits of New
Zealand race (weighing about 1.6–2 kg and 5 months old) were used and
divided randomly into three groups. The animals were kept under standard
conditions at a temperature of 22°C, a humidity of 55%, and a light cycle of
12 h of light and 12 h of darkness to adapt to the environment and food for
about a month. Group 1 (N = 10) served as the control and
received water and normal diet. In Group 2, (N = 10) the
rabbits received lead acetate 547 ppm (Merck Co, Germany) orally in a dose
of 5 mg/L by stomach tube once daily (5 mg Pb dissolved in 1 L
water).[12,17]In Group 3, (N = 10) the rabbits received vitamin C (Sigma Co,
USA) at a dose of 500 mg vitamin C/kg body weight, by stomach tube once and
underwent the same duration of lead exposure(5 mg/L) daily for
40 days.[17,18] Vitamin C powder
was obtained from Sigma company. A 500 mg/kg vitamin C was dissolved in 100
cc water and any rabbit was gavage daily 10 mL distilled water.
At the end of the experiment, blood samples were drawn and the level
of blood lead was calculated using blood lead analyzer (Magellan
Diagnostics, USA). Plasma level of lead was calculated in µg/dL.
Subsequently, cholesterol levels, triglyceride (TG), low-density lipoprotein
(LDL), and high-density lipoprotein (HDL) were determined using
spectrophotometry. However, 10 cc of the blood samples was drawn and dumped
in heparin-sealed plastic tubes and sent immediately to the laboratory to be
measured using Method 8003 American National Institute of Occupational
Safety and Health (NIOSH).After the treatment, the animals were anesthetized by the intravenous injection
of pentobarbital (50 mg/kg) into an external ear vein. Subsequently, they
were sacrificed and their thoracic aorta and coronary arteries were removed
and then the samples were soaked in 10% formalin solution for 48 h. Then,
they were fixed, and after these preparation steps, tissue processing and
passage of tissues were performed according to the usual methods of tissue
laboratories, and then the samples were embedded in paraffin to prepare them
for section cutting on the microtome and were cut with a thickness of 5 μm.
The sections were stained by H & E staining and were studied by light
microscopy of Olympus model of BX51.
Compliance with ethics guidelines
All the procedures performed in this study were in accordance with the
ethical standards of the institutional and/or national research
committee and with the 1964 Helsinki Declaration and its later
amendments or comparable ethical standards. The study was approved by
the Research Ethics Committee of the Faculty of Medicine, Maragheh
University (IR.MARAGHEHPHC.REC.1399.019).
Statistical analyses
The results were analyzed using the Mann–Whitney test. The data were
expressed as mean ± SD and analyzed by Student’s
t-test, and p-values less than 0.05
were considered as significant. The analysis was performed using SPSS
statistical software (version 15, SPSS Inc., Chicago, IL, USA). A
p-value less than 0.05 was considered
significant.
Results
No mortality was observed in any of the rabbits throughout the study. The
results of this study revealed that administration of lead acetate in
rabbits had harmful effects on the endothelium of aorta arteries. These
effects worsened the rupture of the endothelial layer and the formation of
atherosclerosis plaque that was improved by the administration of vitamin C.
(Figure 1
(a)–(c)).
Figure 1.
H & E staining of aorta artery shows the destruction of
endothelium and atherosclerotic plaque in the aorta artery of
Group 2 which received lead acetate (b), while, no development
of atherosclerotic plaque was seen in Group 3 which received
ascorbic acid (c) and Group 1(a). Magnification, 40x.
H & E staining of aorta artery shows the destruction of
endothelium and atherosclerotic plaque in the aorta artery of
Group 2 which received lead acetate (b), while, no development
of atherosclerotic plaque was seen in Group 3 which received
ascorbic acid (c) and Group 1(a). Magnification, 40x.The findings of this study showed that lead acetate could cause lesion and
atherosclerotic plaque in the left coronary artery (Figure 2(b)) that was relatively
improved by the administration of vitamin C, but the endothelium wall was
discontinuous and few blood cells were observed on it compared to the
control groups (Figure
2(a) and (c)).
Figure 2.
H & E staining of left coronary artery shows atherosclerotic
plaque in the coronary artery of Group 2 which received lead
acetate (b), and no development of atherosclerotic plaque was
observed in Group 3 which received ascorbic acid, but few blood
cells aggregation was observed (c), and the control group
without any endothelial defect (a). Magnification, 40x.
H & E staining of left coronary artery shows atherosclerotic
plaque in the coronary artery of Group 2 which received lead
acetate (b), and no development of atherosclerotic plaque was
observed in Group 3 which received ascorbic acid, but few blood
cells aggregation was observed (c), and the control group
without any endothelial defect (a). Magnification, 40x.The results of this study showed the existence of atherosclerotic plaque in the
right coronary artery which received lead acetate (Figure 3(b)), while the
atherosclerotic plaque was not observed in the control group and the group
which had received ascorbic acid (Figure 3(a) and (c)).
Figure 3.
H & E staining of right coronary artery shows the destruction
of endothelial cells by lead acetate and attachment of fatty
streak on endothelium in Group 2 (b), while no lesions in
endothelial cells were observed in Group 1 (a) and the ascorbic
acid-fed group (c). Magnification, 40x.
H & E staining of right coronary artery shows the destruction
of endothelial cells by lead acetate and attachment of fatty
streak on endothelium in Group 2 (b), while no lesions in
endothelial cells were observed in Group 1 (a) and the ascorbic
acid-fed group (c). Magnification, 40x.There was a significant difference between the two groups
(p < 0.05).The results showed an increase in lead levels in Group 2, while a decrease in
lead levels was observed in Group 3 that was fed the vitamin C, and there
was a significant difference between Group 2 and Group 3 (Figure 4).
Figure 4.
Plasma levels of lead (µg/dL) in the control group and experimental
groups. Significant differences were observed between the groups
(p < 0.0001).
Plasma levels of lead (µg/dL) in the control group and experimental
groups. Significant differences were observed between the groups
(p < 0.0001).Moreover, it was shown that lead exposure could change the level of blood
lipids, LDL, TG, and HDL. Vitamin C could increase HDL and decrease LDL, and
TG. Furthermore, there were significant differences between these groups
(Figure
5).
Figure 5.
Plasma levels of TG, LDL, and HDL (mg/dL) in experimental groups
(p < 0.0001).
Plasma levels of TG, LDL, and HDL (mg/dL) in experimental groups
(p < 0.0001).
Discussion
The aim of this study was to evaluate the effects of ascorbic acid on the
endothelium of coronary and aorta arteries in lead-exposed rabbits.
Heavy metals, including cadmium (Cd), arsenic (As), and lead (Pb),
could target the vascular system and damage vascular endothelium in a
variety of ways.
If the vascular endothelial cells were exposed to any toxic metal,
the endothelial cells could be injured or killed.In this study, the results of morphological analysis revealed the formation of
atherosclerotic plaque and destruction of endothelium in the aorta and
coronary arteries that received lead acetate, while, no lesions in
endothelial cells were observed in the control group and the ascorbic
acid-fed group. It was confirmed in this study that exposure to lead acetate
causes histological lesions in endothelium. With respect to the mechanisms
of the harmful effects of heavy metals on the cells, it is noteworthy to
mention that they cause the release of ROS, and consequently, the defensive
line of the cells is weakened or even lost and they cannot eliminate the
ROS. Therefore, the lack of balance between the antioxidants level and the
generation of free radicals can cause oxidative stress on cells.Previous studies have indicated that heavy metals, including cadmium, arsenic,
and lead, could damage the vascular system in a variety of ways. Evidently,
if vascular endothelial cells were exposed to any toxic metals existing in
the blood stream, the endothelial cells could be injured or killed.Moreover, it has been indicated that lead disrupts the production of nitric
oxide in endothelial cells, and damage to endothelial cells is the first and
most important cause of atherosclerosis in blood vessels.The findings of this research confirm the results of previous studies. It has
already been shown that any damages to endothelial cells may lead to CVDs,
particularly the formation of atherosclerotic plaques. Lead causes the
oxidation of LDL, HDL, and various proteins in the vessel wall through the
production of oxygen-free radicals. Atherosclerosis process is associated
with the peroxidation of lipoproteins.Several factors are related with the lead effects, such as blood pressure
elevation, limitation of the Na +, K +-ATPase, enhanced peripheral
resistance, because of endothelial dysfunction with increasing of oxidative
stress, stimulating of the renin–angiotensin system, among others. The
previous studies reported that exposure to lead acetate-induced
hepatotoxicity associated to cause lesion, necrosis, inflammation, and
hemorrhage in the liver and spleen. Alike to other toxic elements, the
lead-induced damages to the cardiovascular system depends on dose/level and
duration of exposure.[15,26]It was found that vitamin C, as an antioxidant, can decrease the level of blood
lead and lipid peroxidation. Hence, it prevents the formation of
atherosclerosis in the arteries in the group that fed lead acetate.Vitamin C can prevent LDL oxidation and lipid peroxidation that may cause
damages to endothelial cells.Moreover, researchers have shown that some substances, including Beta vulgaris
juice, are rich in antioxidants and can scavenge free radicals and decrease
the level of blood lead.Furthermore, it collects essential metals, including lead acetate, calcium, and
iron, and improves blood picture which changed by lead toxicity.Others studies have shown that, vitamin C has chelating capacity for lead, and
it has also been proposed that it can quench the ROS and effects of lead
acetate and has a prophylactic role against lead.[30,31]Vitamin C protects the cells in the body and the cardiovascular system by
facilitating fat metabolism.
It has a significant role in the making the connective tissue, and
protection against the development and progression of atherosclerosis.
Deficiency of vitamin C in blood stream increased the risk factors of
hypertension, myocardial infarction, and CVD.It has been indicated that vitamin C may not scavenge the lead ions.
Studies have reported that vitamin C could be used to treat CVD.
Moreover, it has been indicated that vitamin C may not significantly reduce
blood lead levels in accordance with similar previous findings. It was shown
that treatment by vitamin C may not have any effect on the reduction of the
lead level in vessels and other tissues.This study was conducted to evaluate the effects of ascorbic acid on the
reduction of lead sedimentation in blood vessels and protection of vessels
of endothelium from lead toxic effect. Therefore, the findings of this study
indicated that ascorbic acid could protect the endothelial vessels and
reduce the atherosclerosis induced by lead acetate.Limitations: The major limitation of this research was the
dissection and preservation of the coronary arteries. It is necessary to
provide more samples in the experimental group because some of the samples
were omitted during the dissection of the coronary arteries and tissue
processing that was able to cause statistical problems. Moreover, it was not
possible to measure certain oxidative stress parameters due to their high
costs. Another limitation was the lack of electron microscopy and high cost.
We could not use electron microscopy for studying endothelium. Sample
size/power analysis was not performed for this study.
Conclusion
The results of this study revealed that the administration of lead acetate in
rabbits could have harmful effects on the endothelium of aorta and coronary
arteries. These effects were relatively improved by the administration of
vitamin C. Hence, according to the results of this study, it could be
concluded that ascorbic acid improves the destruction and endothelial
dysfunction in aorta and coronary arteries and prevents the formation of
atherosclerotic plaque.
Authors: Maria Del Carmen Baez; Mariana Taran; Maria de La Paz Scribano; Ariel Balceda; Carla Buonanotte; Sergio Blencio; Ismael Fonseca; Monica Moya Journal: Antiinflamm Antiallergy Agents Med Chem Date: 2017
Authors: Rabea Asleh; Alexandros Briasoulis; Elliot M Berinstein; Joshua B Wiener; Mohan Palla; Sudhir S Kushwaha; Andrew P Levy Journal: Pharmgenomics Pers Med Date: 2018-04-23
Authors: Nadia Z Shaban; Sara E Abd El-Kader; Fayed A K Mogahed; Mohamed A L El-Kersh; Noha H Habashy Journal: Sci Rep Date: 2021-01-08 Impact factor: 4.379